Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance().

A series of cyclic peptides were designed and prepared to investigate the physicochemical properties that affect oral bioavailabilty of this chemotype in rats. In particular, the ionization state of the peptide was examined by the incorporation of naturally occurring amino acid residues that are charged in differing regions of the gut. In addition, data was generated in a variety of in vitro assays and the usefulness of this data in predicting the subsequent oral bioavailability observed in the rat is discussed.

[1]  T. Hakoshima,et al.  Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule , 2010, Proceedings of the National Academy of Sciences.

[2]  Horst Kessler,et al.  Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues. , 2008, Angewandte Chemie.

[3]  Matthew P Jacobson,et al.  Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers. , 2006, Journal of the American Chemical Society.

[4]  P. Sharma,et al.  Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers. , 2005, Farmaco.

[5]  B. Honig,et al.  A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.

[6]  Matthew P. Jacobson,et al.  Predicting and improving the membrane permeability of peptidic small molecules. , 2012, Journal of medicinal chemistry.

[7]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[8]  Matthew P Jacobson,et al.  Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides. , 2006, Journal of the American Chemical Society.

[9]  J. Clardy,et al.  Crystal and molecular structure of BBM-928 A, a novel antitumor antibiotic from Actinomadura luzonensis , 1981 .

[10]  W. Denny,et al.  NMR studies of the interaction of the antibiotic nogalamycin with the hexadeoxyribonucleotide duplex d(5'-GCATGC)2. , 1988, Biochemistry.

[11]  T. Xiang,et al.  Molecular distributions in interphases: statistical mechanical theory combined with molecular dynamics simulation of a model lipid bilayer. , 1994, Biophysical journal.

[12]  S. Harrison,et al.  Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  David B Duignan,et al.  High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models. , 2008, Current drug metabolism.

[14]  Horst Kessler,et al.  Reinvestigation of the Conformation of Cyclosporin A in Chloroform , 1990 .

[15]  Li Di,et al.  Development of a new permeability assay using low-efflux MDCKII cells. , 2011, Journal of pharmaceutical sciences.

[16]  Matthew P. Jacobson,et al.  An atomistic model of passive membrane permeability: application to a series of FDA approved drugs , 2007, J. Comput. Aided Mol. Des..

[17]  Yizhong Zhang,et al.  On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds , 2011, Nature chemical biology.

[18]  Armin Widmer,et al.  Peptide conformations. Part 31. The conformation of cyclosporin a in the crystal and in solution , 1985 .

[19]  T. Xiang,et al.  Phospholipid surface density determines the partitioning and permeability of acetic acid in DMPC:cholesterol bilayers , 1995, The Journal of Membrane Biology.

[20]  Siegfried S. F. Leung,et al.  Testing Physical Models of Passive Membrane Permeation , 2012, J. Chem. Inf. Model..

[21]  Anna Seelig,et al.  The Role of Size and Charge for Blood–Brain Barrier Permeation of Drugs and Fatty Acids , 2007, Journal of Molecular Neuroscience.

[22]  Yehuda Katz,et al.  Interpretation of nonelectrolyte partition coefficients between dimyristoyl lecithin and water , 2005, The Journal of Membrane Biology.

[23]  D. Patel,et al.  Solution structure of the luzopeptin-DNA complex. , 1991, Biochemistry.

[24]  Horst Kessler,et al.  Intestinal permeability of cyclic peptides: common key backbone motifs identified. , 2012, Journal of the American Chemical Society.

[25]  T. Xiang,et al.  The relationship between permeant size and permeability in lipid bilayer membranes , 1993, The Journal of Membrane Biology.